| 0.4 |
1.2 |
GO:1902362 |
melanocyte apoptotic process(GO:1902362) |
| 0.2 |
2.5 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.1 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.4 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.1 |
0.3 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.7 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.1 |
0.3 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.1 |
0.4 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
0.4 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.1 |
2.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.2 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.0 |
0.4 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.0 |
0.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.2 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.0 |
0.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.0 |
0.2 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.0 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) uterine wall breakdown(GO:0042704) |
| 0.0 |
0.6 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.0 |
0.2 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 |
0.1 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
0.6 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.0 |
0.7 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.0 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.0 |
0.2 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.0 |
0.1 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.0 |
0.2 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 |
0.4 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.0 |
0.1 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.5 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.2 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.0 |
0.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 |
0.1 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.0 |
0.2 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) vagus nerve development(GO:0021564) |
| 0.0 |
0.1 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.0 |
0.2 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 |
0.2 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.1 |
GO:0019082 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.0 |
0.1 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.0 |
0.7 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.1 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.0 |
0.1 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.0 |
0.2 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 |
0.2 |
GO:1902162 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.0 |
0.3 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.1 |
GO:0031446 |
regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
| 0.0 |
0.1 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.0 |
0.1 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.0 |
0.2 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.0 |
0.1 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.0 |
0.2 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.0 |
0.1 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.1 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 |
0.1 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.0 |
0.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.1 |
GO:0046671 |
negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.0 |
0.1 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.0 |
0.1 |
GO:2001301 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.0 |
0.1 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) |
| 0.0 |
0.3 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.0 |
0.1 |
GO:0003409 |
optic cup structural organization(GO:0003409) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
0.0 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 0.0 |
0.0 |
GO:0042495 |
toll-like receptor 1 signaling pathway(GO:0034130) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.0 |
0.0 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.0 |
0.2 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.0 |
0.0 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.0 |
0.4 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.0 |
0.1 |
GO:1903906 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.0 |
0.0 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 |
0.3 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.0 |
0.1 |
GO:1990418 |
response to insulin-like growth factor stimulus(GO:1990418) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.1 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.0 |
0.1 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.0 |
0.3 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.2 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.5 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.0 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.0 |
0.0 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.0 |
0.1 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.0 |
0.3 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.1 |
GO:0019427 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.0 |
0.1 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 |
0.2 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.0 |
0.0 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.0 |
0.1 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 |
0.0 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 |
0.1 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.1 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
